Frequencies for first 10,000 rows of indi_pt variable in indi2018q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 7 0.07 0.07 Abdominal pain | 5 0.05 0.12 Abdominal pain upper | 6 0.06 0.18 Abnormal behaviour | 10 0.10 0.28 Abortion spontaneous | 1 0.01 0.29 Abscess | 3 0.03 0.32 Accidental exposure to product | 9 0.09 0.41 Accidental overdose | 1 0.01 0.42 Acidosis | 1 0.01 0.43 Acne | 2 0.02 0.45 Acquired haemophilia | 5 0.05 0.50 Acquired immunodeficiency syndrome | 3 0.03 0.53 Acral overgrowth | 1 0.01 0.54 Acromegaly | 11 0.11 0.65 Acute coronary syndrome | 13 0.13 0.78 Acute lymphocytic leukaemia | 17 0.17 0.95 Acute lymphocytic leukaemia recurrent | 1 0.01 0.96 Acute megakaryocytic leukaemia | 1 0.01 0.97 Acute myeloid leukaemia | 14 0.14 1.11 Acute myocardial infarction | 3 0.03 1.14 Acute sinusitis | 2 0.02 1.16 Adenocarcinoma gastric | 3 0.03 1.19 Adjustment disorder with depressed mood | 2 0.02 1.21 Adjuvant therapy | 1 0.01 1.22 Adrenal insufficiency | 1 0.01 1.23 Adverse drug reaction | 2 0.02 1.25 Adverse event | 29 0.29 1.54 Affective disorder | 12 0.12 1.66 Age-related macular degeneration | 16 0.16 1.82 Agitation | 2 0.02 1.84 Alcoholic liver disease | 2 0.02 1.86 Allergy prophylaxis | 3 0.03 1.89 Allergy test | 7 0.07 1.96 Allergy to arthropod sting | 1 0.01 1.97 Amyloidosis | 2 0.02 1.99 Anaemia | 13 0.13 2.12 Anaemia prophylaxis | 1 0.01 2.13 Anaesthesia | 1 0.01 2.14 Analgesic intervention supportive the.. | 1 0.01 2.15 Analgesic therapy | 7 0.07 2.22 Androgen replacement therapy | 81 0.81 3.03 Androgenetic alopecia | 1 0.01 3.04 Anger | 4 0.04 3.08 Angina pectoris | 4 0.04 3.12 Angioedema | 1 0.01 3.13 Angiomyolipoma | 1 0.01 3.14 Angiopathy | 2 0.02 3.16 Ankylosing spondylitis | 13 0.13 3.29 Anti-VGCC antibody positive | 1 0.01 3.30 Anti-infective therapy | 2 0.02 3.32 Antibiotic level | 1 0.01 3.33 Antibiotic prophylaxis | 1 0.01 3.34 Antibiotic therapy | 6 0.06 3.40 Anticoagulant therapy | 15 0.15 3.55 Antidepressant therapy | 6 0.06 3.61 Antiemetic supportive care | 3 0.03 3.64 Antifungal prophylaxis | 8 0.08 3.72 Antifungal treatment | 3 0.03 3.75 Antiinflammatory therapy | 1 0.01 3.76 Antiphospholipid syndrome | 1 0.01 3.77 Antiplatelet therapy | 2 0.02 3.79 Antipyresis | 1 0.01 3.80 Antiretroviral therapy | 7 0.07 3.87 Antiviral prophylaxis | 2 0.02 3.89 Antiviral treatment | 4 0.04 3.93 Anuria | 1 0.01 3.94 Anxiety | 58 0.58 4.52 Anxiety disorder | 3 0.03 4.55 Anxiolytic therapy | 1 0.01 4.56 Aortic aneurysm | 1 0.01 4.57 Aplastic anaemia | 6 0.06 4.63 Arrhythmia | 10 0.10 4.73 Arrhythmia prophylaxis | 2 0.02 4.75 Arteriosclerosis | 1 0.01 4.76 Arthralgia | 13 0.13 4.89 Arthritis | 22 0.22 5.11 Arthritis bacterial | 5 0.05 5.16 Arthritis infective | 1 0.01 5.17 Arthropathy | 2 0.02 5.19 Arthropod bite | 3 0.03 5.22 Ascites | 2 0.02 5.24 Aspergillus infection | 2 0.02 5.26 Aspergillus test positive | 2 0.02 5.28 Asthenia | 1 0.01 5.29 Asthma | 130 1.30 6.59 Astrocytoma, low grade | 1 0.01 6.60 Atrial fibrillation | 85 0.85 7.45 Atrial flutter | 1 0.01 7.46 Atrioventricular block complete | 1 0.01 7.47 Attention deficit/hyperactivity disor.. | 54 0.54 8.01 Atypical haemolytic uraemic syndrome | 9 0.09 8.10 Atypical mycobacterial infection | 3 0.03 8.13 Autism spectrum disorder | 6 0.06 8.19 Autoimmune haemolytic anaemia | 1 0.01 8.20 Autoimmune thyroiditis | 2 0.02 8.22 Autonomic nervous system imbalance | 2 0.02 8.24 Autonomic neuropathy | 2 0.02 8.26 B-cell lymphoma | 29 0.29 8.55 Back disorder | 2 0.02 8.57 Back injury | 1 0.01 8.58 Back pain | 20 0.20 8.78 Balance disorder | 1 0.01 8.79 Barrett's oesophagus | 2 0.02 8.81 Basal cell carcinoma | 2 0.02 8.83 Behavioural therapy | 2 0.02 8.85 Benign prostatic hyperplasia | 14 0.14 8.99 Bile duct cancer | 3 0.03 9.02 Bipolar I disorder | 9 0.09 9.11 Bipolar disorder | 66 0.66 9.77 Bladder cancer | 2 0.02 9.79 Bladder disorder | 4 0.04 9.83 Bladder dysfunction | 1 0.01 9.84 Bladder pain | 18 0.18 10.02 Bladder spasm | 2 0.02 10.04 Bladder transitional cell carcinoma | 1 0.01 10.05 Blast crisis in myelogenous leukaemia | 2 0.02 10.07 Blood calcium | 1 0.01 10.08 Blood cholesterol | 16 0.16 10.24 Blood cholesterol abnormal | 18 0.18 10.42 Blood cholesterol increased | 22 0.22 10.64 Blood disorder | 1 0.01 10.65 Blood glucose | 1 0.01 10.66 Blood glucose abnormal | 3 0.03 10.69 Blood glucose increased | 2 0.02 10.71 Blood growth hormone decreased | 1 0.01 10.72 Blood iron | 1 0.01 10.73 Blood iron decreased | 1 0.01 10.74 Blood potassium decreased | 2 0.02 10.76 Blood pressure abnormal | 31 0.31 11.07 Blood pressure increased | 4 0.04 11.11 Blood pressure management | 1 0.01 11.12 Blood pressure measurement | 26 0.26 11.38 Blood testosterone decreased | 47 0.47 11.85 Blood triglycerides abnormal | 1 0.01 11.86 Blood triglycerides increased | 1 0.01 11.87 Blood uric acid increased | 2 0.02 11.89 Body height below normal | 11 0.11 12.00 Bone density abnormal | 1 0.01 12.01 Bone density decreased | 3 0.03 12.04 Bone disorder | 4 0.04 12.08 Bone loss | 3 0.03 12.11 Bone marrow conditioning regimen | 18 0.18 12.29 Bone marrow transplant | 4 0.04 12.33 Bone pain | 3 0.03 12.36 Bowel movement irregularity | 2 0.02 12.38 Bradycardia | 1 0.01 12.39 Brain neoplasm benign | 1 0.01 12.40 Breakthrough pain | 8 0.08 12.48 Breast cancer | 63 0.63 13.11 Breast cancer female | 1 0.01 13.12 Breast cancer metastatic | 40 0.40 13.52 Breast cancer stage III | 3 0.03 13.55 Bronchitis | 7 0.07 13.62 Bronchitis chronic | 2 0.02 13.64 Bronchopulmonary aspergillosis | 2 0.02 13.66 Bronchopulmonary aspergillosis allergic | 1 0.01 13.67 Burkitt's lymphoma | 15 0.15 13.82 Burning sensation | 3 0.03 13.85 Calculus urinary | 2 0.02 13.87 Cancer pain | 1 0.01 13.88 Candida infection | 1 0.01 13.89 Carcinoid syndrome | 2 0.02 13.91 Carcinoid tumour | 6 0.06 13.97 Cardiac amyloidosis | 2 0.02 13.99 Cardiac arrest | 1 0.01 14.00 Cardiac disorder | 53 0.53 14.53 Cardiac failure | 14 0.14 14.67 Cardiac failure chronic | 12 0.12 14.79 Cardiac failure congestive | 6 0.06 14.85 Cardiac stress test | 1 0.01 14.86 Cardiac valve disease | 1 0.01 14.87 Cardiomyopathy | 3 0.03 14.90 Cardiovascular disorder | 5 0.05 14.95 Cardiovascular event prophylaxis | 8 0.08 15.03 Carotid artery disease | 1 0.01 15.04 Cataplexy | 6 0.06 15.10 Cataract operation | 3 0.03 15.13 Cellulitis | 1 0.01 15.14 Central nervous system lymphoma | 5 0.05 15.19 Cerebral artery occlusion | 1 0.01 15.20 Cerebral disorder | 1 0.01 15.21 Cerebral haemorrhage | 1 0.01 15.22 Cerebral infarction | 4 0.04 15.26 Cerebral thrombosis | 1 0.01 15.27 Cerebrovascular accident | 1 0.01 15.28 Cerebrovascular accident prophylaxis | 38 0.38 15.66 Chemotherapy | 31 0.31 15.97 Chemotherapy multiple agents systemic | 1 0.01 15.98 Chest pain | 5 0.05 16.03 Cholecystitis | 2 0.02 16.05 Cholinergic syndrome | 1 0.01 16.06 Chondropathy | 3 0.03 16.09 Chronic gastritis | 2 0.02 16.11 Chronic graft versus host disease | 1 0.01 16.12 Chronic hepatitis B | 1 0.01 16.13 Chronic hepatitis C | 4 0.04 16.17 Chronic infantile neurological cutane.. | 4 0.04 16.21 Chronic inflammatory demyelinating po.. | 2 0.02 16.23 Chronic kidney disease | 6 0.06 16.29 Chronic kidney disease-mineral and bo.. | 2 0.02 16.31 Chronic lymphocytic leukaemia | 11 0.11 16.42 Chronic myeloid leukaemia | 112 1.12 17.54 Chronic obstructive pulmonary disease | 51 0.51 18.05 Chronic spontaneous urticaria | 2 0.02 18.07 Clostridium difficile infection | 1 0.01 18.08 Coagulopathy | 6 0.06 18.14 Coeliac disease | 3 0.03 18.17 Cognitive disorder | 2 0.02 18.19 Colitis ulcerative | 25 0.25 18.44 Colon cancer | 17 0.17 18.61 Colon cancer metastatic | 1 0.01 18.62 Colorectal cancer | 24 0.24 18.86 Colorectal cancer metastatic | 43 0.43 19.29 Complex regional pain syndrome | 4 0.04 19.33 Conduct disorder | 3 0.03 19.36 Confusional state | 2 0.02 19.38 Constipation | 28 0.28 19.66 Constipation prophylaxis | 1 0.01 19.67 Contraception | 13 0.13 19.80 Cor pulmonale chronic | 1 0.01 19.81 Coronary arterial stent insertion | 8 0.08 19.89 Coronary artery disease | 46 0.46 20.35 Coronary artery occlusion | 2 0.02 20.37 Cough | 9 0.09 20.46 Craniocerebral injury | 2 0.02 20.48 Crohn's disease | 42 0.42 20.90 Cystic fibrosis | 11 0.11 21.01 Cystitis | 1 0.01 21.02 Cystitis interstitial | 1 0.01 21.03 Deaf mutism | 4 0.04 21.07 Deafness neurosensory | 4 0.04 21.11 Decreased appetite | 4 0.04 21.15 Deep vein thrombosis | 17 0.17 21.32 Dehydration | 1 0.01 21.33 Delusion | 1 0.01 21.34 Dementia | 5 0.05 21.39 Dementia Alzheimer's type | 14 0.14 21.53 Depression | 171 1.71 23.24 Dermatitis allergic | 1 0.01 23.25 Device related infection | 3 0.03 23.28 Device therapy | 1 0.01 23.29 Diabetes insipidus | 1 0.01 23.30 Diabetes mellitus | 129 1.29 24.59 Diabetic foot | 1 0.01 24.60 Diabetic neuropathy | 17 0.17 24.77 Diabetic retinal oedema | 3 0.03 24.80 Diabetic retinopathy | 2 0.02 24.82 Diarrhoea | 14 0.14 24.96 Diffuse large B-cell lymphoma | 27 0.27 25.23 Diffuse large B-cell lymphoma stage I | 5 0.05 25.28 Disability | 1 0.01 25.29 Dislocation of vertebra | 1 0.01 25.30 Disseminated intravascular coagulation | 1 0.01 25.31 Disturbance in attention | 2 0.02 25.33 Diuretic therapy | 9 0.09 25.42 Diverticulitis | 1 0.01 25.43 Diverticulum | 2 0.02 25.45 Diverticulum intestinal | 3 0.03 25.48 Dizziness | 2 0.02 25.50 Drug abuse | 18 0.18 25.68 Drug dependence | 2 0.02 25.70 Drug eruption | 1 0.01 25.71 Drug hypersensitivity | 3 0.03 25.74 Drug withdrawal maintenance therapy | 1 0.01 25.75 Dry eye | 5 0.05 25.80 Dry mouth | 1 0.01 25.81 Dry skin | 2 0.02 25.83 Dwarfism | 4 0.04 25.87 Dyslipidaemia | 20 0.20 26.07 Dysmenorrhoea | 7 0.07 26.14 Dyspepsia | 18 0.18 26.32 Dyspnoea | 15 0.15 26.47 Dysuria | 1 0.01 26.48 Electroencephalogram abnormal | 1 0.01 26.49 Electrolyte imbalance | 2 0.02 26.51 Electrolyte substitution therapy | 1 0.01 26.52 Embolism | 2 0.02 26.54 Emotional disorder | 1 0.01 26.55 Emphysema | 8 0.08 26.63 End stage renal disease | 2 0.02 26.65 Endometrial hyperplasia | 1 0.01 26.66 Endometriosis | 1 0.01 26.67 Enterocolitis | 6 0.06 26.73 Eosinophilic oesophagitis | 1 0.01 26.74 Epidural anaesthesia | 4 0.04 26.78 Epidural analgesia | 1 0.01 26.79 Epigastric discomfort | 1 0.01 26.80 Epilepsy | 37 0.37 27.17 Erectile dysfunction | 15 0.15 27.32 Erythema | 1 0.01 27.33 Erythema multiforme | 3 0.03 27.36 Essential hypertension | 3 0.03 27.39 Essential thrombocythaemia | 1 0.01 27.40 Essential tremor | 1 0.01 27.41 Excessive cerumen production | 1 0.01 27.42 Exposure during pregnancy | 1 0.01 27.43 Eye disorder | 1 0.01 27.44 Eye infection | 3 0.03 27.47 Fabry's disease | 6 0.06 27.53 Factor V Leiden mutation | 1 0.01 27.54 Factor VIII deficiency | 3 0.03 27.57 Faeces hard | 1 0.01 27.58 Fallopian tube cancer | 4 0.04 27.62 Familial mediterranean fever | 2 0.02 27.64 Fatigue | 4 0.04 27.68 Febrile convulsion | 1 0.01 27.69 Febrile neutropenia | 16 0.16 27.85 Feeling of relaxation | 1 0.01 27.86 Female sterilisation | 1 0.01 27.87 Fibromyalgia | 28 0.28 28.15 Flatulence | 1 0.01 28.16 Fluid replacement | 2 0.02 28.18 Fluid retention | 6 0.06 28.24 Focal dyscognitive seizures | 3 0.03 28.27 Foetal exposure during pregnancy | 1 0.01 28.28 Fracture | 1 0.01 28.29 Fungal infection | 2 0.02 28.31 Gait disturbance | 7 0.07 28.38 Gastric cancer | 7 0.07 28.45 Gastric disorder | 12 0.12 28.57 Gastric ulcer | 7 0.07 28.64 Gastritis | 8 0.08 28.72 Gastritis prophylaxis | 5 0.05 28.77 Gastroenteritis | 2 0.02 28.79 Gastrointestinal disorder | 3 0.03 28.82 Gastrointestinal neoplasm | 1 0.01 28.83 Gastrointestinal pain | 1 0.01 28.84 Gastrointestinal stromal tumour | 10 0.10 28.94 Gastrooesophageal reflux disease | 97 0.97 29.91 Gaucher's disease | 6 0.06 29.97 Generalised anxiety disorder | 3 0.03 30.00 Generalised tonic-clonic seizure | 3 0.03 30.03 Genital herpes | 1 0.01 30.04 Genital herpes simplex | 1 0.01 30.05 Gestational diabetes | 2 0.02 30.07 Gingivitis | 1 0.01 30.08 Glaucoma | 11 0.11 30.19 Glioblastoma | 8 0.08 30.27 Glioblastoma multiforme | 2 0.02 30.29 Glomerulonephritis membranoproliferat.. | 1 0.01 30.30 Glucose tolerance impaired | 1 0.01 30.31 Gout | 11 0.11 30.42 Graft versus host disease | 3 0.03 30.45 Granulomatosis with polyangiitis | 2 0.02 30.47 Growth failure | 1 0.01 30.48 Growth hormone deficiency | 20 0.20 30.68 Growth of eyelashes | 3 0.03 30.71 Growth retardation | 1 0.01 30.72 Guttate psoriasis | 1 0.01 30.73 HER-2 positive breast cancer | 33 0.33 31.06 HER-2 positive gastric cancer | 3 0.03 31.09 HIV infection | 80 0.80 31.89 Haematemesis | 1 0.01 31.90 Haematopoietic stem cell mobilisation | 1 0.01 31.91 Haemoglobin | 1 0.01 31.92 Haemolysis | 1 0.01 31.93 Haemolytic uraemic syndrome | 9 0.09 32.02 Haemorrhage | 1 0.01 32.03 Haemostasis | 1 0.01 32.04 Hair disorder | 3 0.03 32.07 Hallucination | 1 0.01 32.08 Head and neck cancer | 1 0.01 32.09 Headache | 20 0.20 32.29 Heart rate increased | 3 0.03 32.32 Heart rate irregular | 3 0.03 32.35 Heart transplant | 1 0.01 32.36 Hepatic failure | 1 0.01 32.37 Hepatic function abnormal | 2 0.02 32.39 Hepatic pain | 1 0.01 32.40 Hepatitis | 1 0.01 32.41 Hepatitis B | 5 0.05 32.46 Hepatitis C | 2 0.02 32.48 Hepatocellular carcinoma | 1 0.01 32.49 Herpes zoster | 2 0.02 32.51 Hiatus hernia | 2 0.02 32.53 Hodgkin's disease | 8 0.08 32.61 Hormone replacement therapy | 18 0.18 32.79 Hormone-refractory prostate cancer | 2 0.02 32.81 Hot flush | 1 0.01 32.82 Human herpesvirus 6 infection | 1 0.01 32.83 Hyperammonaemia | 1 0.01 32.84 Hypercalcaemia | 2 0.02 32.86 Hyperchloraemia | 2 0.02 32.88 Hypercholesterolaemia | 25 0.25 33.13 Hyperglycaemia | 3 0.03 33.16 Hyperinsulinaemic hypoglycaemia | 2 0.02 33.18 Hyperkalaemia | 1 0.01 33.19 Hyperlipidaemia | 18 0.18 33.37 Hyperparathyroidism | 1 0.01 33.38 Hyperphosphataemia | 6 0.06 33.44 Hypersensitivity | 33 0.33 33.77 Hypertension | 338 3.38 37.15 Hypertensive crisis | 2 0.02 37.17 Hypertensive heart disease | 2 0.02 37.19 Hyperthyroidism | 4 0.04 37.23 Hypertonic bladder | 4 0.04 37.27 Hyperuricaemia | 6 0.06 37.33 Hypoaesthesia | 2 0.02 37.35 Hypocalcaemia | 1 0.01 37.36 Hypogonadism | 21 0.21 37.57 Hypokalaemia | 4 0.04 37.61 Hyponatraemia | 1 0.01 37.62 Hypopituitarism | 7 0.07 37.69 Hypotension | 1 0.01 37.70 Hypothalamo-pituitary disorder | 1 0.01 37.71 Hypothyroidism | 37 0.37 38.08 Hypotonia | 2 0.02 38.10 Hypovitaminosis | 1 0.01 38.11 Hypovolaemia | 1 0.01 38.12 Ill-defined disorder | 6 0.06 38.18 Immune system disorder | 1 0.01 38.19 Immune thrombocytopenic purpura | 6 0.06 38.25 Immunosuppressant drug therapy | 15 0.15 38.40 Immunosuppression | 4 0.04 38.44 Impaired gastric emptying | 1 0.01 38.45 Impulsive behaviour | 4 0.04 38.49 Incontinence | 2 0.02 38.51 Infection | 14 0.14 38.65 Infection prophylaxis | 10 0.10 38.75 Inflammation | 2 0.02 38.77 Inflammatory bowel disease | 1 0.01 38.78 Influenza | 7 0.07 38.85 Influenza like illness | 3 0.03 38.88 Injury | 1 0.01 38.89 Injury associated with device | 2 0.02 38.91 Insomnia | 54 0.54 39.45 Insulinoma | 1 0.01 39.46 Intentional overdose | 1 0.01 39.47 Interstitial lung disease | 2 0.02 39.49 Intervertebral disc degeneration | 2 0.02 39.51 Intervertebral disc injury | 2 0.02 39.53 Intervertebral disc protrusion | 1 0.01 39.54 Intervertebral discitis | 1 0.01 39.55 Intestinal fistula | 2 0.02 39.57 Intestinal obstruction | 2 0.02 39.59 Intraocular lens implant | 1 0.01 39.60 Intraocular pressure increased | 2 0.02 39.62 Intraocular pressure test abnormal | 2 0.02 39.64 Invasive ductal breast carcinoma | 2 0.02 39.66 Iridocyclitis | 1 0.01 39.67 Iritis | 1 0.01 39.68 Iron deficiency anaemia | 2 0.02 39.70 Iron overload | 6 0.06 39.76 Irritable bowel syndrome | 3 0.03 39.79 Ischaemic stroke | 1 0.01 39.80 Juvenile idiopathic arthritis | 3 0.03 39.83 Kidney transplant rejection | 1 0.01 39.84 Labour induction | 1 0.01 39.85 Learning disorder | 3 0.03 39.88 Lesion excision | 1 0.01 39.89 Leukopenia | 2 0.02 39.91 Lipids abnormal | 1 0.01 39.92 Liver disorder | 7 0.07 39.99 Liver function test abnormal | 1 0.01 40.00 Liver transplant | 5 0.05 40.05 Localised infection | 2 0.02 40.07 Loss of personal independence in dail.. | 1 0.01 40.08 Low density lipoprotein increased | 2 0.02 40.10 Lower respiratory tract infection | 2 0.02 40.12 Lower urinary tract symptoms | 2 0.02 40.14 Lung adenocarcinoma | 12 0.12 40.26 Lung adenocarcinoma stage III | 2 0.02 40.28 Lung carcinoma cell type unspecified .. | 1 0.01 40.29 Lung disorder | 4 0.04 40.33 Lung neoplasm malignant | 4 0.04 40.37 Lupus nephritis | 30 0.30 40.67 Lymphoma | 9 0.09 40.76 Major depression | 4 0.04 40.80 Malaise | 1 0.01 40.81 Malaria | 1 0.01 40.82 Malignant glioma | 2 0.02 40.84 Malignant melanoma | 6 0.06 40.90 Malignant melanoma stage IV | 1 0.01 40.91 Mantle cell lymphoma | 6 0.06 40.97 Maternal exposure timing unspecified | 6 0.06 41.03 Maternal therapy to enhance foetal lu.. | 1 0.01 41.04 Medulloblastoma recurrent | 2 0.02 41.06 Menopausal symptoms | 1 0.01 41.07 Menopause | 5 0.05 41.12 Menorrhagia | 4 0.04 41.16 Mental disorder | 18 0.18 41.34 Metastases to bone | 18 0.18 41.52 Metastases to liver | 8 0.08 41.60 Metastases to lung | 1 0.01 41.61 Metastases to ovary | 2 0.02 41.63 Metastases to peritoneum | 2 0.02 41.65 Metastasis | 1 0.01 41.66 Metastatic carcinoid tumour | 2 0.02 41.68 Metastatic malignant melanoma | 15 0.15 41.83 Metastatic renal cell carcinoma | 13 0.13 41.96 Micturition disorder | 2 0.02 41.98 Migraine | 31 0.31 42.29 Migraine prophylaxis | 2 0.02 42.31 Mineral supplementation | 3 0.03 42.34 Mitral valve prolapse | 1 0.01 42.35 Monoclonal gammopathy | 1 0.01 42.36 Mononucleosis syndrome | 1 0.01 42.37 Mood swings | 2 0.02 42.39 Movement disorder | 2 0.02 42.41 Mucopolysaccharidosis II | 1 0.01 42.42 Mucopolysaccharidosis VI | 1 0.01 42.43 Multiple allergies | 8 0.08 42.51 Multiple sclerosis | 174 1.74 44.25 Multiple sclerosis relapse | 5 0.05 44.30 Muscle building therapy | 1 0.01 44.31 Muscle relaxant therapy | 2 0.02 44.33 Muscle spasms | 11 0.11 44.44 Muscle spasticity | 2 0.02 44.46 Musculoskeletal pain | 2 0.02 44.48 Myalgia | 1 0.01 44.49 Myasthenia gravis | 1 0.01 44.50 Myasthenic syndrome | 1 0.01 44.51 Mycobacterium marinum infection | 2 0.02 44.53 Mycosis fungoides | 3 0.03 44.56 Myelodysplastic syndrome | 13 0.13 44.69 Myelofibrosis | 14 0.14 44.83 Myeloproliferative neoplasm | 4 0.04 44.87 Myocardial infarction | 4 0.04 44.91 Myocardial ischaemia | 18 0.18 45.09 Myositis | 1 0.01 45.10 Nail disorder | 3 0.03 45.13 Narcolepsy | 7 0.07 45.20 Nasopharyngitis | 3 0.03 45.23 Nausea | 30 0.30 45.53 Neck pain | 2 0.02 45.55 Neoplasm | 5 0.05 45.60 Neoplasm malignant | 2 0.02 45.62 Neoplasm progression | 2 0.02 45.64 Neovascular age-related macular degen.. | 2 0.02 45.66 Nephrogenic anaemia | 147 1.47 47.13 Nephrolithiasis | 1 0.01 47.14 Nerve compression | 2 0.02 47.16 Nerve injury | 4 0.04 47.20 Nervous system disorder | 2 0.02 47.22 Nervousness | 1 0.01 47.23 Neuralgia | 23 0.23 47.46 Neuroblastoma | 6 0.06 47.52 Neuroendocrine carcinoma | 5 0.05 47.57 Neuroendocrine carcinoma metastatic | 3 0.03 47.60 Neuroendocrine tumour | 18 0.18 47.78 Neurological symptom | 1 0.01 47.79 Neuromyelitis optica spectrum disorder | 2 0.02 47.81 Neuropathy peripheral | 27 0.27 48.08 Nightmare | 1 0.01 48.09 Nocturia | 3 0.03 48.12 Non-Hodgkin's lymphoma | 33 0.33 48.45 Non-small cell lung cancer | 17 0.17 48.62 Non-small cell lung cancer metastatic | 3 0.03 48.65 Non-small cell lung cancer stage IV | 1 0.01 48.66 Nuclear magnetic resonance imaging he.. | 1 0.01 48.67 Nutritional supplementation | 9 0.09 48.76 Obsessive-compulsive disorder | 2 0.02 48.78 Oedema | 8 0.08 48.86 Oedema due to hepatic disease | 3 0.03 48.89 Oedema peripheral | 2 0.02 48.91 Oesophageal adenocarcinoma | 3 0.03 48.94 Oesophageal candidiasis | 2 0.02 48.96 Oesophageal disorder | 1 0.01 48.97 Off label use | 2 0.02 48.99 Opportunistic infection prophylaxis | 1 0.01 49.00 Oppositional defiant disorder | 5 0.05 49.05 Oral candidiasis | 2 0.02 49.07 Oral fungal infection | 3 0.03 49.10 Oral herpes | 2 0.02 49.12 Organising pneumonia | 1 0.01 49.13 Oropharyngeal pain | 1 0.01 49.14 Osteitis deformans | 4 0.04 49.18 Osteoarthritis | 6 0.06 49.24 Osteomyelitis | 5 0.05 49.29 Osteonecrosis | 2 0.02 49.31 Osteopenia | 72 0.72 50.03 Osteoporosis | 186 1.86 51.89 Osteoporosis postmenopausal | 6 0.06 51.95 Osteoporosis prophylaxis | 10 0.10 52.05 Ovarian cancer | 18 0.18 52.23 Ovarian cancer recurrent | 2 0.02 52.25 Ovarian cyst | 3 0.03 52.28 Overdose | 4 0.04 52.32 Pain | 159 1.59 53.91 Pain in extremity | 11 0.11 54.02 Pain management | 1 0.01 54.03 Palpitations | 1 0.01 54.04 Pancreas transplant | 1 0.01 54.05 Pancreatic carcinoma | 14 0.14 54.19 Pancreatic carcinoma metastatic | 3 0.03 54.22 Pancreatic failure | 4 0.04 54.26 Pancreatic neuroendocrine tumour | 2 0.02 54.28 Pancreatic neuroendocrine tumour meta.. | 1 0.01 54.29 Pancytopenia | 1 0.01 54.30 Panic attack | 6 0.06 54.36 Panic disorder | 2 0.02 54.38 Paraesthesia | 3 0.03 54.41 Paralysis | 2 0.02 54.43 Paranoia | 2 0.02 54.45 Parathyroidectomy | 1 0.01 54.46 Parkinson's disease | 4 0.04 54.50 Parkinsonian gait | 1 0.01 54.51 Paroxysmal nocturnal haemoglobinuria | 8 0.08 54.59 Partial seizures | 5 0.05 54.64 Pelvic inflammatory disease | 2 0.02 54.66 Pemphigoid | 1 0.01 54.67 Peptic ulcer | 7 0.07 54.74 Percutaneous coronary intervention | 1 0.01 54.75 Performance status decreased | 1 0.01 54.76 Pericarditis | 1 0.01 54.77 Perioperative analgesia | 3 0.03 54.80 Peripheral arterial occlusive disease | 6 0.06 54.86 Peripheral artery thrombosis | 7 0.07 54.93 Peripheral blood stem cell apheresis | 1 0.01 54.94 Peripheral swelling | 2 0.02 54.96 Peripheral vascular disorder | 1 0.01 54.97 Peritoneal carcinoma metastatic | 7 0.07 55.04 Personality disorder | 2 0.02 55.06 Petit mal epilepsy | 1 0.01 55.07 Pharyngitis | 5 0.05 55.12 Phenylketonuria | 1 0.01 55.13 Philadelphia chromosome positive | 1 0.01 55.14 Pituitary cyst | 1 0.01 55.15 Pituitary tumour | 1 0.01 55.16 Pituitary tumour benign | 1 0.01 55.17 Pityriasis | 3 0.03 55.20 Plasma cell myeloma | 55 0.55 55.75 Plasma cell myeloma recurrent | 4 0.04 55.79 Plasmacytoma | 3 0.03 55.82 Pleural effusion | 1 0.01 55.83 Pneumocystis jirovecii pneumonia | 2 0.02 55.85 Pneumonia | 14 0.14 55.99 Pollakiuria | 2 0.02 56.01 Polyarthritis | 1 0.01 56.02 Polycythaemia vera | 2 0.02 56.04 Polyneuropathy | 2 0.02 56.06 Polypoidal choroidal vasculopathy | 1 0.01 56.07 Polyuria | 3 0.03 56.10 Post laminectomy syndrome | 2 0.02 56.12 Post-traumatic stress disorder | 9 0.09 56.21 Postoperative analgesia | 1 0.01 56.22 Postoperative care | 4 0.04 56.26 Postural orthostatic tachycardia synd.. | 1 0.01 56.27 Pregnancy | 2 0.02 56.29 Premedication | 111 1.11 57.40 Premenstrual syndrome | 1 0.01 57.41 Primary hypothyroidism | 1 0.01 57.42 Primary immunodeficiency syndrome | 1 0.01 57.43 Primary myelofibrosis | 4 0.04 57.47 Primitive neuroectodermal tumour | 6 0.06 57.53 Procedural pain | 3 0.03 57.56 Product use in unapproved indication | 1 0.01 57.57 Product used for unknown indication | 2,523 25.23 82.80 Prophylactic chemotherapy | 6 0.06 82.86 Prophylaxis | 196 1.96 84.82 Prophylaxis against HIV infection | 5 0.05 84.87 Prophylaxis against gastrointestinal .. | 10 0.10 84.97 Prophylaxis against graft versus host.. | 24 0.24 85.21 Prophylaxis against transplant reject.. | 12 0.12 85.33 Prophylaxis of nausea and vomiting | 2 0.02 85.35 Prophylaxis of neural tube defect | 2 0.02 85.37 Prophylaxis urinary tract infection | 1 0.01 85.38 Prostate cancer | 17 0.17 85.55 Prostate cancer metastatic | 5 0.05 85.60 Prostatomegaly | 3 0.03 85.63 Pruritus | 5 0.05 85.68 Pseudomonas infection | 3 0.03 85.71 Pseudomyxoma peritonei | 1 0.01 85.72 Psoriasis | 51 0.51 86.23 Psoriatic arthropathy | 23 0.23 86.46 Psychotic disorder | 25 0.25 86.71 Psychotic symptom | 1 0.01 86.72 Pulmonary arterial hypertension | 29 0.29 87.01 Pulmonary congestion | 1 0.01 87.02 Pulmonary embolism | 8 0.08 87.10 Pulmonary fibrosis | 1 0.01 87.11 Pulmonary hypertension | 15 0.15 87.26 Pulmonary tuberculosis | 4 0.04 87.30 Pustular psoriasis | 3 0.03 87.33 Pyrexia | 24 0.24 87.57 Radiculopathy | 3 0.03 87.60 Radioembolisation | 1 0.01 87.61 Radiotherapy | 1 0.01 87.62 Radiotherapy to bone | 1 0.01 87.63 Rash | 6 0.06 87.69 Raynaud's phenomenon | 2 0.02 87.71 Rectal cancer | 16 0.16 87.87 Rectal cancer metastatic | 4 0.04 87.91 Reflux gastritis | 1 0.01 87.92 Relapsing-remitting multiple sclerosis | 14 0.14 88.06 Relaxation therapy | 1 0.01 88.07 Renal cancer | 3 0.03 88.10 Renal cancer metastatic | 5 0.05 88.15 Renal cancer stage IV | 1 0.01 88.16 Renal cell carcinoma | 12 0.12 88.28 Renal cell carcinoma stage IV | 3 0.03 88.31 Renal disorder | 6 0.06 88.37 Renal failure | 3 0.03 88.40 Renal impairment | 1 0.01 88.41 Renal transplant | 25 0.25 88.66 Respiratory disorder | 1 0.01 88.67 Respiratory symptom | 1 0.01 88.68 Respiratory tract congestion | 2 0.02 88.70 Restless legs syndrome | 7 0.07 88.77 Restlessness | 10 0.10 88.87 Retinal detachment | 1 0.01 88.88 Retinal neovascularisation | 1 0.01 88.89 Rheumatic disorder | 5 0.05 88.94 Rheumatoid arthritis | 308 3.08 92.02 Rhinitis | 1 0.01 92.03 Rhinitis allergic | 1 0.01 92.04 Right ventricular failure | 2 0.02 92.06 Routine health maintenance | 1 0.01 92.07 SLE arthritis | 1 0.01 92.08 Schizoaffective disorder | 8 0.08 92.16 Schizoaffective disorder bipolar type | 3 0.03 92.19 Schizoaffective disorder depressive t.. | 2 0.02 92.21 Schizophrenia | 96 0.96 93.17 Sciatic nerve injury | 1 0.01 93.18 Sciatica | 3 0.03 93.21 Scleroderma | 2 0.02 93.23 Scoliosis | 1 0.01 93.24 Seasonal allergy | 1 0.01 93.25 Seborrhoeic dermatitis | 1 0.01 93.26 Secondary progressive multiple sclero.. | 2 0.02 93.28 Sedation | 4 0.04 93.32 Sedative therapy | 1 0.01 93.33 Seizure | 24 0.24 93.57 Sensory disturbance | 2 0.02 93.59 Sepsis | 3 0.03 93.62 Septo-optic dysplasia | 1 0.01 93.63 Sexual dysfunction | 2 0.02 93.65 Sialoadenitis | 1 0.01 93.66 Sickle cell anaemia | 10 0.10 93.76 Sinus operation | 2 0.02 93.78 Sinusitis | 2 0.02 93.80 Sjogren's syndrome | 1 0.01 93.81 Skin burning sensation | 1 0.01 93.82 Skin disorder | 3 0.03 93.85 Skin irritation | 1 0.01 93.86 Skin test | 3 0.03 93.89 Skin ulcer | 3 0.03 93.92 Skin wrinkling | 1 0.01 93.93 Sleep apnoea syndrome | 1 0.01 93.94 Sleep disorder | 28 0.28 94.22 Sleep disorder therapy | 4 0.04 94.26 Small for dates baby | 2 0.02 94.28 Smoking cessation therapy | 5 0.05 94.33 Somnolence | 1 0.01 94.34 Spinal column stenosis | 2 0.02 94.36 Spinal osteoarthritis | 5 0.05 94.41 Spinal pain | 1 0.01 94.42 Splenic infarction | 2 0.02 94.44 Spondylitis | 3 0.03 94.47 Spondylolisthesis | 4 0.04 94.51 Squamous cell carcinoma of head and n.. | 3 0.03 94.54 Staphylococcal infection | 5 0.05 94.59 Status epilepticus | 1 0.01 94.60 Stem cell transplant | 23 0.23 94.83 Stent placement | 5 0.05 94.88 Still's disease | 4 0.04 94.92 Stomatitis | 3 0.03 94.95 Stress | 1 0.01 94.96 Stress urinary incontinence | 2 0.02 94.98 Stroke volume decreased | 1 0.01 94.99 Substance abuse | 4 0.04 95.03 Suicidal ideation | 1 0.01 95.04 Superior vena cava occlusion | 2 0.02 95.06 Supplementation therapy | 18 0.18 95.24 Supportive care | 2 0.02 95.26 Swelling | 3 0.03 95.29 Synovitis | 1 0.01 95.30 Systemic lupus erythematosus | 29 0.29 95.59 Systemic mastocytosis | 1 0.01 95.60 Systemic scleroderma | 3 0.03 95.63 Tachycardia | 4 0.04 95.67 Temporal arteritis | 1 0.01 95.68 Thalassaemia beta | 1 0.01 95.69 Thinking abnormal | 1 0.01 95.70 Thrombocytopenia | 1 0.01 95.71 Thrombocytosis | 1 0.01 95.72 Thrombophlebitis | 1 0.01 95.73 Thrombosis | 3 0.03 95.76 Thrombosis prophylaxis | 65 0.65 96.41 Thyroid cancer | 1 0.01 96.42 Thyroid disorder | 20 0.20 96.62 Thyroidectomy | 3 0.03 96.65 Tic | 2 0.02 96.67 Tobacco user | 1 0.01 96.68 Tonsillitis | 1 0.01 96.69 Tooth abscess | 1 0.01 96.70 Toothache | 1 0.01 96.71 Tourette's disorder | 2 0.02 96.73 Tracheobronchitis | 2 0.02 96.75 Transgender operation | 1 0.01 96.76 Transitional cell carcinoma | 1 0.01 96.77 Transplant | 13 0.13 96.90 Transplant failure | 1 0.01 96.91 Transplant rejection | 2 0.02 96.93 Tremor | 1 0.01 96.94 Trigeminal nerve disorder | 1 0.01 96.95 Trigeminal neuralgia | 2 0.02 96.97 Tuberculosis | 2 0.02 96.99 Tuberous sclerosis complex | 1 0.01 97.00 Tumour pain | 2 0.02 97.02 Turner's syndrome | 1 0.01 97.03 Type 1 diabetes mellitus | 14 0.14 97.17 Type 2 diabetes mellitus | 180 1.80 98.97 Type IIa hyperlipidaemia | 3 0.03 99.00 Ulcer | 2 0.02 99.02 Upper gastrointestinal haemorrhage | 1 0.01 99.03 Upper respiratory tract inflammation | 2 0.02 99.05 Urge incontinence | 4 0.04 99.09 Urinary incontinence | 3 0.03 99.12 Urinary retention | 2 0.02 99.14 Urinary tract disorder | 2 0.02 99.16 Urinary tract infection | 16 0.16 99.32 Urinary tract obstruction | 2 0.02 99.34 Urticaria | 2 0.02 99.36 Uterine leiomyoma | 4 0.04 99.40 Uterine polyp | 2 0.02 99.42 Varicose vein | 1 0.01 99.43 Vasculitis | 2 0.02 99.45 Vein disorder | 2 0.02 99.47 Venous thrombosis | 1 0.01 99.48 Ventricular arrhythmia | 1 0.01 99.49 Ventricular tachycardia | 1 0.01 99.50 Vertebral osteophyte | 1 0.01 99.51 Vertebrobasilar insufficiency | 1 0.01 99.52 Vertigo | 1 0.01 99.53 Vision blurred | 1 0.01 99.54 Vitamin D decreased | 1 0.01 99.55 Vitamin D deficiency | 7 0.07 99.62 Vitamin K deficiency | 1 0.01 99.63 Vitamin supplementation | 5 0.05 99.68 Vitreous haemorrhage | 1 0.01 99.69 Vomiting | 17 0.17 99.86 Vulvovaginal dryness | 1 0.01 99.87 Waldenstrom's macroglobulinaemia | 2 0.02 99.89 Weight control | 6 0.06 99.95 Wheezing | 5 0.05 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 8 Sep 2018